Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Estimated Prevalence and Incidence of Multiple Sclerosis in Iran Publisher Pubmed



Etemadifar M1 ; Izadi S2 ; Nikseresht A2 ; Sharifian M2 ; Sahraian MA3 ; Nasr Z1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Research Committee of Multiple Sclerosis (IRCOMS), Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Shiraz Neurosciences Research Center, Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. MSRC, Isfahan University of Medical Sciences, Isfahan, Iran

Source: European Neurology Published:2014


Abstract

Background: Multiple Sclerosis (MS) is a chronic demyelinating disease of the central nervous system and its epidemiology has changed in recent years. Previously, Iran was considered to have a low MS prevalence. In this study, we aimed to update the prevalence and incidence of MS in Iran. Patients and Methods: This study was conducted based on the data derived from the new report of Iran's Ministry Of Health and Medical Education (MOHME) regarding the patients who have registered to obtain support for treatment in Iran till the end of 2013. Results: Among the 42,200 registered patients, 32,477 were female and 9,723 were male (sex ratio: 3.34: 1), and 4,545 were diagnosed in 2013. This resulted in a prevalence of 54.51 and an incidence of 5.87 per 100,000. Conclusion: According to our study results, Iran has a medium-to-high prevalence rate of MS. According to the previous epidemiologic studies from Iran, it seems that the prevalence of MS significantly has increased during recent years. This rate is similar to what is seen in many western countries. © 2014 S. Karger AG, Basel.
Related Docs
View other Related Docs
1. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
2. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
3. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
4. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
5. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
6. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
7. Prevalence of Multiple Sclerosis in Iranian Emigrants: Review of the Evidence, Neurological Sciences (2016)
8. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (123)
Masoud Etemadifar (122)
Other Related Docs
9. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
10. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
11. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)
12. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
13. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018, CNS Drugs (2021)
14. Characteristics of Familial Multiple Sclerosis in Isfahan, Iran: A Cross-Sectional Study, Neurology Asia (2014)
15. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
16. Multiple Sclerosis Among Afghan Immigrants in Isfahan, Iran, Multiple Sclerosis and Related Disorders (2017)
17. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
18. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
19. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
20. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
21. A Case-Control Study of Risk Factors for Multiple Sclerosis in Iran, Multiple Sclerosis Journal (2011)
22. The Higher Prevalence of Multiple Sclerosis Among Iranian Georgians; New Clues to the Role of Genetic Factors, Revue Neurologique (2020)
23. Increasing Female Preponderance of Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2010)
24. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
25. The Prevalence of the Genetic Polymorphism of Gstm1, Gstt1 and Gstp1 and Its Relationship With Clinical Criteria of Multiple Sclerosis (Ms) Patients in Tehran, Journal of Babol University of Medical Sciences (2019)
26. Cost of Illness of Multiple Sclerosis in Isfahan, Iran, From a Social Perspective: A Comparison of the Human-Capital and Friction-Cost Methods, Value in Health Regional Issues (2022)
27. The Role of Information System in Multiple Sclerosis Management, Journal of Research in Medical Sciences (2014)
28. Clinical and Demographical Characteristics of Primary Progressive Multiple Sclerosis in Isfahan, Iran, European Journal of Neurology (2007)
29. Il-23 Plasma Level Measurement in Relapsing Remitting Multiple Sclerosis (Rrms) Patients Compared to Healthy Subjects, Immunological Investigations (2015)
30. The Prevalence of Multiple Sclerosis (Ms) in Oceania, a Systematic Review, and Meta-Analysis, Neurological Sciences (2024)
31. Social Aspects of Multiple Sclerosis for Iranian Individuals, Disability and Rehabilitation (2015)
32. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2022)
33. Short-Term Effects of Prolonged Fasting on Multiple Sclerosis, European Neurology (2009)
34. Multiple Sclerosis and Environmental Risk Factors: A Case-Control Study in Iran, Neurological Sciences (2017)
35. Cancer and Mortality Risks Among People With Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, PLoS ONE (2024)
36. The Role of Parental Consanguinity and Familial Aggregation in Development of Multiple Sclerosis: A Case-Control Study, European journal of medical research (2024)
37. Childhood-Onset Multiple Sclerosis: Report of 82 Patients From Isfahan, Iran, Archives of Iranian Medicine (2007)
38. Epileptic Seizures in Multiple Sclerosis: A Population-Based Survey in Iran, Acta Neurologica Belgica (2013)
39. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
40. Worldwide Prevalence of Neuromyelitis Optica Spectrum Disorder (Nmosd) and Neuromyelitis Optica (Nmo): A Systematic Review and Meta-Analysis, Neurological Sciences (2023)
41. Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis, Journal of Education and Health Promotion (2021)
42. Estimated Incidence Rate of Multiple Sclerosis and Its Relationship With Geographical Factors in Isfahan Province Between the Years 2001 and 2014, International Journal of Preventive Medicine (2018)
43. Epidemiological and Clinical Features of Pediatric-Onset Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, Between 1997-2020, Current Journal of Neurology (2021)
44. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
45. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
46. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
47. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
48. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
49. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
50. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)